Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR / CYP2J2 axis
The FASEB Journal · 31.10.2024 · 38 (20)
DOI: 10.1096/fj.202401489r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 23.10.2024. Verfasst von Shiqi Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Third XiangYa Hospital Central South University, Changsha, Hunan, P. R. China. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2J2, Diabetic Nephropathies, Ergocalciferols, Receptors, Calcitriol. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), 2021 Hunan Provincial Clinical Medical Technology Innovation Guidance Project, 2024 Hunan Provincial Administration of Traditional Chinese Medicine Scientific Research Project.
Abstract (Originalsprache)
Previous studies have shown that paricalcitol (PA) has a protective effect on the kidneys. However, the exact molecular mechanism by which PA affects diabetic nephropathy (DN) progression remains uncertain. PBMCs of patients with DN were isolated, and CYP2J2 and VDR levels were detected by qPCR. Pearson correlation analysis was utilized to detect the relationship between uACR and CYP2J2 and VDR and between CYP2J2 and VDR. The protective effects of PA on DN have been examined by TUNEL, HE staining, ELISA, and Flow cytometry assays in STZ‐induced mice. Moreover, THP‐1 cells were stimulated with HG/LPS for in vitro studies. ELISA, qPCR, western blot, and Flow cytometry assays were utilized to assess the effects of PA on DN progression by regulating CYP2J2. The interaction between CYP2J2 and VDR was analyzed by CHIP‐qPCR and luciferase experiments. CYP2J2 and VDR levels were downregulated and uACR level was upregulated in DN patients. CYP2J2 and VDR were positively correlated in PBMCs. Both CYP2J2 and VDR are inversely correlated with uACR. Moreover, after PA treatment, 11, 12‐EET levels increased, inflammatory factor levels decreased, and M2 macrophage polarization was promoted in STZ‐induced mice and HG/LPS‐triggered THP‐1 cells. Depletion of CYP2J2 and VDR decreased 11, 12‐EET level, enhanced inflammatory factor levels, and inhibited M2 macrophage polarization, which were reversed by CYP2J2 overexpression in HG/LPS‐treated cells. Furthermore, VDR bound to the CYP2J2 promoter and promoted CYP2J2 transcriptional expression. The present work pointed out a new use for PA to inhibit DN progression by increasing EET level, inhibiting inflammatory response, and inducing M2 macrophage polarization via regulating the VDR/CYP2J2 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The Third XiangYa Hospital Central South University, Changsha, Hunan, P. R. China.
- Department of Nephrology, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan, P. R. China.
ORCID-Profile: Shiqi Tang, Jun Tan, Shikun Yang, Aimei Li, Jishi Liu, Wei Zhang, Hao Zhang, Yan Liu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- 2021 Hunan Provincial Clinical Medical Technology Innovation Guidance Project
- 2024 Hunan Provincial Administration of Traditional Chinese Medicine Scientific Research Project
- Science and Technology Innovation Program of Hunan Province
- Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University
- National Natural Science Foundation of China
Zitieren
APA
Tang, S., Tan, J., Yang, S., Li, A., Liu, J., Zhang, W., Zhang, H., & Liu, Y. (2024). Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR / CYP2J2 axis. The FASEB Journal, 38(20). https://doi.org/10.1096/fj.202401489r
Vancouver
Tang S, Tan J, Yang S, Li A, Liu J, Zhang W, et al. Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR / CYP2J2 axis. The FASEB Journal. 2024;38(20). doi:10.1096/fj.202401489r
BibTeX
@article{Tang2024,
author = {Tang, Shiqi and Tan, Jun and Yang, Shikun and Li, Aimei and Liu, Jishi and Zhang, Wei and Zhang, Hao and Liu, Yan},
title = {Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR / CYP2J2 axis},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {20},
doi = {10.1096/fj.202401489r}
}
EUVIMED